Table of Contents Chapter 1 Overview of Penicillin and Streptomycin 1.1 Definition of Penicillin and Streptomycin in This Report 1.2 Commercial Types of Penicillin and Streptomycin 1.2.1 Penicillin 1.2.2 Streptomycin 1.3 Downstream Application of Penicillin and Streptomycin 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Others 1.4 Development History of Penicillin and Streptomycin 1.5 Market Status and Trend of Penicillin and Streptomycin 2013-2023 1.5.1 United States Penicillin and Streptomycin Market Status and Trend 2013-2023 1.5.2 Regional Penicillin and Streptomycin Market Status and Trend 2013-2023 Chapter 2 United States Market Status and Forecast by Regions 2.1 Market Status of Penicillin and Streptomycin in United States 2013-2017 2.2 Consumption Market of Penicillin and Streptomycin in United States by Regions 2.2.1 Consumption Volume of Penicillin and Streptomycin in United States by Regions 2.2.2 Revenue of Penicillin and Streptomycin in United States by Regions 2.3 Market Analysis of Penicillin and Streptomycin in United States by Regions 2.3.1 Market Analysis of Penicillin and Streptomycin in New England 2013-2017 2.3.2 Market Analysis of Penicillin and Streptomycin in The Middle Atlantic 2013-2017 2.3.3 Market Analysis of Penicillin and Streptomycin in The Midwest 2013-2017 2.3.4 Market Analysis of Penicillin and Streptomycin in The West 2013-2017 2.3.5 Market Analysis of Penicillin and Streptomycin in The South 2013-2017 2.3.6 Market Analysis of Penicillin and Streptomycin in Southwest 2013-2017 2.4 Market Development Forecast of Penicillin and Streptomycin in United States 2018-2023 2.4.1 Market Development Forecast of Penicillin and Streptomycin in United States 2018-2023 2.4.2 Market Development Forecast of Penicillin and Streptomycin by Regions 2018-2023 Chapter 3 United States Market Status and Forecast by Types 3.1 Whole United States Market Status by Types 3.1.1 Consumption Volume of Penicillin and Streptomycin in United States by Types 3.1.2 Revenue of Penicillin and Streptomycin in United States by Types 3.2 United States Market Status by Types in Major Countries 3.2.1 Market Status by Types in New England 3.2.2 Market Status by Types in The Middle Atlantic 3.2.3 Market Status by Types in The Midwest 3.2.4 Market Status by Types in The West 3.2.5 Market Status by Types in The South 3.2.6 Market Status by Types in Southwest 3.3 Market Forecast of Penicillin and Streptomycin in United States by Types Chapter 4 United States Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Penicillin and Streptomycin in United States by Downstream Industry 4.2 Demand Volume of Penicillin and Streptomycin by Downstream Industry in Major Countries 4.2.1 Demand Volume of Penicillin and Streptomycin by Downstream Industry in New England 4.2.2 Demand Volume of Penicillin and Streptomycin by Downstream Industry in The Middle Atlantic 4.2.3 Demand Volume of Penicillin and Streptomycin by Downstream Industry in The Midwest 4.2.4 Demand Volume of Penicillin and Streptomycin by Downstream Industry in The West 4.2.5 Demand Volume of Penicillin and Streptomycin by Downstream Industry in The South 4.2.6 Demand Volume of Penicillin and Streptomycin by Downstream Industry in Southwest 4.3 Market Forecast of Penicillin and Streptomycin in United States by Downstream Industry Chapter 5 Market Driving Factor Analysis of Penicillin and Streptomycin 5.1 United States Economy Situation and Trend Overview 5.2 Penicillin and Streptomycin Downstream Industry Situation and Trend Overview Chapter 6 Penicillin and Streptomycin Market Competition Status by Major Players in United States 6.1 Sales Volume of Penicillin and Streptomycin in United States by Major Players 6.2 Revenue of Penicillin and Streptomycin in United States by Major Players 6.3 Basic Information of Penicillin and Streptomycin by Major Players 6.3.1 Headquarters Location and Established Time of Penicillin and Streptomycin Major Players 6.3.2 Employees and Revenue Level of Penicillin and Streptomycin Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Penicillin and Streptomycin Major Manufacturers Introduction and Market Data 7.1 Johnson & Johnson 7.1.1 Company profile 7.1.2 Representative Penicillin and Streptomycin Product 7.1.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Johnson & Johnson 7.2 Pfizer 7.2.1 Company profile 7.2.2 Representative Penicillin and Streptomycin Product 7.2.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Pfizer 7.3 Bayer HealthCare 7.3.1 Company profile 7.3.2 Representative Penicillin and Streptomycin Product 7.3.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Bayer HealthCare 7.4 Abbot Laboratories 7.4.1 Company profile 7.4.2 Representative Penicillin and Streptomycin Product 7.4.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Abbot Laboratories 7.5 Roche Pharmaceuticals 7.5.1 Company profile 7.5.2 Representative Penicillin and Streptomycin Product 7.5.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Roche Pharmaceuticals 7.6 Sanofi Aventis 7.6.1 Company profile 7.6.2 Representative Penicillin and Streptomycin Product 7.6.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Sanofi Aventis 7.7 Takeda Pharmaceutical Company 7.7.1 Company profile 7.7.2 Representative Penicillin and Streptomycin Product 7.7.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Takeda Pharmaceutical Company 7.8 Toyama Chemical 7.8.1 Company profile 7.8.2 Representative Penicillin and Streptomycin Product 7.8.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Toyama Chemical 7.9 Merck & Co. 7.9.1 Company profile 7.9.2 Representative Penicillin and Streptomycin Product 7.9.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Merck & Co. 7.10 MiddleBrook Pharmaceuticals 7.10.1 Company profile 7.10.2 Representative Penicillin and Streptomycin Product 7.10.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of MiddleBrook Pharmaceuticals 7.11 Novartis 7.11.1 Company profile 7.11.2 Representative Penicillin and Streptomycin Product 7.11.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Novartis 7.12 Biogen IDEC 7.12.1 Company profile 7.12.2 Representative Penicillin and Streptomycin Product 7.12.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Biogen IDEC 7.13 Bristol Myers Squibb 7.13.1 Company profile 7.13.2 Representative Penicillin and Streptomycin Product 7.13.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Bristol Myers Squibb 7.14 Celgine Corporation 7.14.1 Company profile 7.14.2 Representative Penicillin and Streptomycin Product 7.14.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Celgine Corporation 7.15 Eli Lilly and Co 7.15.1 Company profile 7.15.2 Representative Penicillin and Streptomycin Product 7.15.3 Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Eli Lilly and Co 7.16 Gilead Sciences 7.17 GlaxoSmithKline 7.18 Amgen 7.19 Astellas Pharma 7.20 Astra Zeneca Chapter 8 Upstream and Downstream Market Analysis of Penicillin and Streptomycin 8.1 Industry Chain of Penicillin and Streptomycin 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Penicillin and Streptomycin 9.1 Cost Structure Analysis of Penicillin and Streptomycin 9.2 Raw Materials Cost Analysis of Penicillin and Streptomycin 9.3 Labor Cost Analysis of Penicillin and Streptomycin 9.4 Manufacturing Expenses Analysis of Penicillin and Streptomycin Chapter 10 Marketing Status Analysis of Penicillin and Streptomycin 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Penicillin Table Advantage and Disadvantage of Streptomycin Table Consumption Volume of Penicillin and Streptomycin in United States by Regions 2013-2017 Table Revenue of Penicillin and Streptomycin in United States by Regions 2013-2017 Table Consumption Volume of Penicillin and Streptomycin in United States by Regions 2018-2023 Table Revenue of Penicillin and Streptomycin in United States by Regions 2018-2023 Table Consumption Volume of Penicillin and Streptomycin in United States by Types 2013-2017 Table Revenue of Penicillin and Streptomycin in United States by Types 2013-2017 Table Consumption Volume of Penicillin and Streptomycin by Types in New England 2013-2017 Table Consumption Volume of Penicillin and Streptomycin by Types in The Middle Atlantic 2013-2017 Table Consumption Volume of Penicillin and Streptomycin by Types in The Midwest 2013-2017 Table Consumption Volume of Penicillin and Streptomycin by Types in The West 2013-2017 Table Consumption Volume of Penicillin and Streptomycin by Types in The South 2013-2017 Table Consumption Volume of Penicillin and Streptomycin by Types in Southwest 2013-2017 Table Consumption Volume Forecast of Penicillin and Streptomycin in United States by Types 2018-2023 Table Revenue Forecast of Penicillin and Streptomycin in United States by Types 2018-2023 Table Demand Volume of Penicillin and Streptomycin in United States by Downstream Industry 2013-2017 Table Demand Volume of Penicillin and Streptomycin by Downstream Industry in New England 2013-2017 Table Demand Volume of Penicillin and Streptomycin by Downstream Industry in The Middle Atlantic 2013-2017 Table Demand Volume of Penicillin and Streptomycin by Downstream Industry in The Midwest 2013-2017 Table Demand Volume of Penicillin and Streptomycin by Downstream Industry in The West 2013-2017 Table Demand Volume of Penicillin and Streptomycin by Downstream Industry in The South 2013-2017 Table Demand Volume of Penicillin and Streptomycin by Downstream Industry in Southwest 2013-2017 Table Demand Volume Forecast of Penicillin and Streptomycin in United States by Downstream Industry 2018-2023 Table Sales Volume of Penicillin and Streptomycin in United States by Major Players 2013-2017 Table Revenue of Penicillin and Streptomycin in United States by Major Players 2013-2017 Table Headquarters Location and Established Time of Penicillin and Streptomycin Major Players Table Employees and Revenue Level of Penicillin and Streptomycin Major Players Table Representative Penicillin and Streptomycin Product One of Johnson & Johnson Table Representative Penicillin and Streptomycin Product Two of Johnson & Johnson Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Penicillin and Streptomycin Product One of Pfizer Table Representative Penicillin and Streptomycin Product Two of Pfizer Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Penicillin and Streptomycin Product One of Bayer HealthCare Table Representative Penicillin and Streptomycin Product Two of Bayer HealthCare Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Bayer HealthCare 2013-2017 Table Representative Penicillin and Streptomycin Product One of Abbot Laboratories Table Representative Penicillin and Streptomycin Product Two of Abbot Laboratories Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Abbot Laboratories 2013-2017 Table Representative Penicillin and Streptomycin Product One of Roche Pharmaceuticals Table Representative Penicillin and Streptomycin Product Two of Roche Pharmaceuticals Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Roche Pharmaceuticals 2013-2017 Table Representative Penicillin and Streptomycin Product One of Sanofi Aventis Table Representative Penicillin and Streptomycin Product Two of Sanofi Aventis Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Sanofi Aventis 2013-2017 Table Representative Penicillin and Streptomycin Product One of Takeda Pharmaceutical Company Table Representative Penicillin and Streptomycin Product Two of Takeda Pharmaceutical Company Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Takeda Pharmaceutical Company 2013-2017 Table Representative Penicillin and Streptomycin Product One of Toyama Chemical Table Representative Penicillin and Streptomycin Product Two of Toyama Chemical Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Toyama Chemical 2013-2017 Table Representative Penicillin and Streptomycin Product One of Merck & Co. Table Representative Penicillin and Streptomycin Product Two of Merck & Co. Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Merck & Co. 2013-2017 Table Representative Penicillin and Streptomycin Product One of MiddleBrook Pharmaceuticals Table Representative Penicillin and Streptomycin Product Two of MiddleBrook Pharmaceuticals Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of MiddleBrook Pharmaceuticals 2013-2017 Table Representative Penicillin and Streptomycin Product One of Novartis Table Representative Penicillin and Streptomycin Product Two of Novartis Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Novartis 2013-2017 Table Representative Penicillin and Streptomycin Product One of Biogen IDEC Table Representative Penicillin and Streptomycin Product Two of Biogen IDEC Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Biogen IDEC 2013-2017 Table Representative Penicillin and Streptomycin Product One of Bristol Myers Squibb Table Representative Penicillin and Streptomycin Product Two of Bristol Myers Squibb Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Bristol Myers Squibb 2013-2017 Table Representative Penicillin and Streptomycin Product One of Celgine Corporation Table Representative Penicillin and Streptomycin Product Two of Celgine Corporation Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Celgine Corporation 2013-2017 Table Representative Penicillin and Streptomycin Product One of Eli Lilly and Co Table Representative Penicillin and Streptomycin Product Two of Eli Lilly and Co Table Penicillin and Streptomycin Sales, Revenue, Price and Gross Margin of Eli Lilly and Co 2013-2017